Breakthrough Chemistry, Inc. (BKTH)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Pharmaceuticals	18.92K	13.82K	16.72K
Total	18.92K	13.82K	16.72K

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Canada	18.92K	13.82K	16.72K
Total	18.92K	13.82K	16.72K

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error